Your browser doesn't support javascript.
loading
Dimethyl itaconate selectively targets inflammatory and metabolic pathways in chronic lymphocytic leukemia.
Sana, Ilenia; Mantione, Maria Elena; Meloni, Miriam; Riba, Michela; Ranghetti, Pamela; Scarfò, Lydia; Ghia, Paolo; Muzio, Marta.
Afiliação
  • Sana I; Cell signaling Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Mantione ME; Cell signaling Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Meloni M; Cell signaling Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Riba M; Center for Omics Sciences, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Ranghetti P; B-cell neoplasia Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Scarfò L; B-cell neoplasia Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Ghia P; Vita-Salute San Raffaele University, Milano, Italy.
  • Muzio M; B-cell neoplasia Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milano, Italy.
Eur J Immunol ; 53(10): e2350418, 2023 10.
Article em En | MEDLINE | ID: mdl-37561992

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article